Organization
Scripps Health
3 clinical trials
2 abstracts
Clinical trial
Optimal Conditioning Regimen Protocol for Autologous Hematopoietic Stem Cell Transplantation of Relapsing Remitting Multiple SclerosisStatus: Withdrawn, Estimated PCD: 2027-07-01
Clinical trial
A Single Arm Phase II Pilot Study of Low Dose Vemurafenib Plus Rituximab in the Front-line and Relapsed/Refractory Treatment of Hairy Cell LeukemiaStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Adverse Events Questionnaire for Low Dose Atropine Eye DropsStatus: Completed, Estimated PCD: 2023-01-09
Abstract
Antineoplastic and immunomodulating agent effects on immunization outcomes.Org: Scripps Clinic/Green Hospital, Whittier Diabetes Institute, Scripps Health, Scripps Research Translational Institute, Center for Organ & Cell Transplant,
Abstract
Using SMS technology to improve quality of life and symptom management in the breast cancer patient population: A feasibility study.Org: Scripps Health, Scripps MD Anderson Cancer Center,